{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T16:18:39Z","timestamp":1778516319287,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.healun.2021.02.004","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T23:55:48Z","timestamp":1613606148000},"page":"513-524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Survival implications of prescription opioid and benzodiazepine use in lung transplant recipients: Analysis of linked transplant registry and pharmacy fill records"],"prefix":"10.1016","volume":"40","author":[{"given":"Krista L.","family":"Lentine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo R.","family":"Salvalaggio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasar","family":"Caliskan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ngan N.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mara","family":"McAdams-DeMarco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Axelrod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorry L.","family":"Segev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larissa","family":"Myaskovsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Amanda","family":"Dew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Bruschwein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah J.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Sweet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory P.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertram L.","family":"Kasiske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Schnitzler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3 Suppl","key":"10.1016\/j.healun.2021.02.004_bib0001","doi-asserted-by":"crossref","first-page":"ES9","DOI":"10.36076\/ppj.2012\/15\/ES9","article-title":"Opioid epidemic in the United States","volume":"15","author":"Manchikanti","year":"2012","journal-title":"Pain physician"},{"key":"10.1016\/j.healun.2021.02.004_bib0002","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.pain.2004.09.019","article-title":"Opioids in chronic non-cancer pain: systematic review of efficacy and safety","volume":"112","author":"Kalso","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.healun.2021.02.004_bib0003","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1001\/jama.2011.370","article-title":"Association between opioid prescribing patterns and opioid overdose-related deaths","volume":"305","author":"Bohnert","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.healun.2021.02.004_bib0004","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0919","article-title":"Exposure-Response Association Between Concurrent Opioid and Benzodiazepine Use and Risk of Opioid-Related Overdose in Medicare Part D Beneficiaries","volume":"1","author":"Hernandez","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.healun.2021.02.004_bib0005","doi-asserted-by":"crossref","first-page":"j760","DOI":"10.1136\/bmj.j760","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis","volume":"356","author":"Sun","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.healun.2021.02.004_bib0006","doi-asserted-by":"crossref","first-page":"e14005","DOI":"10.1111\/ctr.14005","article-title":"Outcome implications of benzodiazepine and opioid co-prescription in kidney transplant recipients","volume":"34","author":"Lam","year":"2020","journal-title":"Clin Transplant"},{"key":"10.1016\/j.healun.2021.02.004_bib0007","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1001\/jama.2013.5794","article-title":"Opioid analgesics\u2013risky drugs, not risky patients","volume":"309","author":"Dowell","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.healun.2021.02.004_bib0008","doi-asserted-by":"crossref","first-page":"1602529","DOI":"10.1183\/13993003.02529-2016","article-title":"Incident opioid use is associated with risk of respiratory harm in non-palliative COPD","volume":"49","author":"Vozoris","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2021.02.004_bib0009","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00228-017-2278-3","article-title":"Adverse cardiac events associated with incident opioid drug use among older adults with COPD","volume":"73","author":"Vozoris","year":"2017","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.healun.2021.02.004_bib0010","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1177\/0269216314566839","article-title":"Outcomes of lung transplant candidates referred for co-management by palliative care: a retrospective case series","volume":"29","author":"Colman","year":"2015","journal-title":"Palliat Med"},{"key":"10.1016\/j.healun.2021.02.004_bib0011","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1378\/chest.12-0830","article-title":"Barriers to optimal palliative care of lung transplant candidates","volume":"143","author":"Colman","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.healun.2021.02.004_bib0012","first-page":"69","article-title":"Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline","volume":"18","author":"Marciniuk","year":"2011","journal-title":"Can Respir J"},{"key":"10.1016\/j.healun.2021.02.004_bib0013","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/resp.13012","article-title":"Global strategy for the diagnosis, management and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary","volume":"22","author":"Vogelmeier","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.healun.2021.02.004_bib0014","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMcp1502514","article-title":"Clinical practice. Generalized anxiety disorder","volume":"373","author":"Stein","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2021.02.004_bib0015","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1097\/TP.0000000000003050","article-title":"Pretransplant opioid use and survival after lung transplantation","volume":"104","author":"Vahidy","year":"2020","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2021.02.004_bib0016","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1111\/crj.12948","article-title":"Chronic opioid use and clinical outcomes in lung transplant recipients: a single-center cohort study","volume":"12","author":"Drees","year":"2018","journal-title":"Clin Respir J"},{"key":"10.1016\/j.healun.2021.02.004_bib0017","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13054-019-2394-9","article-title":"Sedation practices and clinical outcomes in mechanically ventilated patients in a prospective multicenter cohort","volume":"23","author":"Aragon","year":"2019","journal-title":"Crit Care"},{"issue":"suppl 3","key":"10.1016\/j.healun.2021.02.004_bib0018","first-page":"395","article-title":"Opioid and benzodiazepine use in lung transplant candidates: A national survey of policies and practices","volume":"19","author":"Bruschwein H","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2021.02.004_bib0019","unstructured":"OPTN (Organ Procurement and Transplantation Network)\/UNOS (United Network for Organ Sharing). OPTN Policies. Policy 10: Allocation of Lungs Web site, 226-28. Available at: http:\/\/optn.transplant.hrsa.gov\/governance\/policies."},{"key":"10.1016\/j.healun.2021.02.004_bib0020","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/j.1600-6143.2006.01276.x","article-title":"Development of the new lung allocation system in the United States","volume":"6","author":"Egan","year":"2006","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2021.02.004_bib0021","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/lt.24714","article-title":"Survival implications of opioid use before and after liver transplantation","volume":"23","author":"Randall","year":"2017","journal-title":"Liver Transpl"},{"key":"10.1016\/j.healun.2021.02.004_bib0022","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1111\/ajt.15565","article-title":"Prescription opioid use before and after heart transplant: associations with posttransplant outcomes","volume":"19","author":"Lentine","year":"2019","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2021.02.004_bib0023","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000377685","article-title":"Associations of pre-transplant prescription narcotic use with clinical complications after kidney transplantation","volume":"41","author":"Lentine","year":"2015","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.healun.2021.02.004_bib0024","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0885-3924(01)00294-9","article-title":"Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing","volume":"22","author":"Pereira","year":"2001","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.healun.2021.02.004_bib0025","series-title":"Bonica's Management of Pain","first-page":"1172","article-title":"Opioid analgesics","author":"Inturrisi","year":"2010"},{"key":"10.1016\/j.healun.2021.02.004_bib0026","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/TP.0000000000000248","article-title":"Quantifying prognostic impact of prescription opioid use before kidney transplantation through linked registry and pharmaceutical claims data","volume":"99","author":"Lentine","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2021.02.004_bib0027","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1111\/ajt.14714","article-title":"Prescription opioid use before and after kidney transplant: implications for posttransplant outcomes","volume":"18","author":"Lentine","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2021.02.004_bib0028","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/ajt.14033","article-title":"Predonation prescription opioid use: A novel risk factor for readmission after living kidney donation","volume":"17","author":"Lentine","year":"2017","journal-title":"Am J Tranplant"},{"key":"10.1016\/j.healun.2021.02.004_bib0029","first-page":"67","article-title":"Coding accuracy of administrative drug claims in the Ontario Drug Benefit database","volume":"10","author":"Levy","year":"2003","journal-title":"Can J Clin Pharmacol"},{"key":"10.1016\/j.healun.2021.02.004_bib0030","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0895-4356(97)00040-1","article-title":"Validation of pharmacy records in drug exposure assessment","volume":"50","author":"Lau","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.healun.2021.02.004_bib0031","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00561403","article-title":"Recording of drug prescriptions in the county of Jamtland, Sweden. II. Drug exposure of pregnant women in relation to course and outcome of pregnancy","volume":"12","author":"Boethius","year":"1977","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.healun.2021.02.004_bib0032","doi-asserted-by":"crossref","first-page":"207","DOI":"10.5055\/jom.2017.0389","article-title":"Characteristics and treatment patterns of US commercially insured and Medicaid patients with opioid dependence or abuse","volume":"13","author":"Wollschlaeger","year":"2017","journal-title":"J Opioid Manag"},{"key":"10.1016\/j.healun.2021.02.004_bib0033","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1080\/10826084.2016.1276189","article-title":"Alcohol and Drug Use and Aberrant Drug-Related Behavior Among Patients on Chronic Opioid Therapy","volume":"52","author":"Campbell","year":"2017","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.healun.2021.02.004_bib0034","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1111\/j.1600-6143.2009.02798.x","article-title":"Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression","volume":"9","author":"Pinsky","year":"2009","journal-title":"Am J Transplant"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105324982102177X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105324982102177X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:40:45Z","timestamp":1760949645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105324982102177X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S105324982102177X"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2021.02.004","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survival implications of prescription opioid and benzodiazepine use in lung transplant recipients: Analysis of linked transplant registry and pharmacy fill records","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2021.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Society for Heart and Lung Transplantation. All rights reserved.","name":"copyright","label":"Copyright"}]}}